The global market for Gastric Mucosal Protective Drug was valued at US$ 1235 million in the year 2024 and is projected to reach a revised size of US$ 1480 million by 2031, growing at a CAGR of 2.4% during the forecast period.

Gastric Mucosal Protective Drug Market

Gastric mucosal protective drugs are medications designed to strengthen the defense mechanisms of the stomach lining and prevent or treat mucosal damage. These agents work by forming a protective barrier on the gastric wall, stimulating mucus and prostaglandin production, and improving local blood flow, thereby shielding the stomach from harmful effects of acid, bile, and irritant drugs. They are commonly used in the treatment of gastritis, peptic ulcers, and in patients requiring long-term NSAID therapy.

North American market for Gastric Mucosal Protective Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Gastric Mucosal Protective Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Gastric Mucosal Protective Drug in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Gastric Mucosal Protective Drug include Otsuka Pharmaceutical, Eisai Co., Zhejaing Yuanlijian, Amneal Pharmaceuticals, Teva, Endo International, Guangdong Huanan Pharma, Viatris, Nostrum Pharmaceuticals, LIVZON, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Gastric Mucosal Protective Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastric Mucosal Protective Drug.

The Gastric Mucosal Protective Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastric Mucosal Protective Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gastric Mucosal Protective Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gastric Mucosal Protective Drug Market Report

Report Metric	Details
Report Name	Gastric Mucosal Protective Drug Market
Accounted market size in year	US$ 1235 million
Forecasted market size in 2031	US$ 1480 million
CAGR	2.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Rebamipide Sucralfate Bismuth Potassium Citrate Other
Segment by Application	Hospital Retail Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Otsuka Pharmaceutical, Eisai Co., Zhejaing Yuanlijian, Amneal Pharmaceuticals, Teva, Endo International, Guangdong Huanan Pharma, Viatris, Nostrum Pharmaceuticals, LIVZON, AbbVie, Bayer, Astellas Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastric Mucosal Protective Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Gastric Mucosal Protective Drug Market growing?

Ans: The Gastric Mucosal Protective Drug Market witnessing a CAGR of 2.4% during the forecast period 2025-2031.

What is the Gastric Mucosal Protective Drug Market size in 2031?

Ans: The Gastric Mucosal Protective Drug Market size in 2031 will be US$ 1480 million.

Who are the main players in the Gastric Mucosal Protective Drug Market report?

Ans: The main players in the Gastric Mucosal Protective Drug Market are Otsuka Pharmaceutical, Eisai Co., Zhejaing Yuanlijian, Amneal Pharmaceuticals, Teva, Endo International, Guangdong Huanan Pharma, Viatris, Nostrum Pharmaceuticals, LIVZON, AbbVie, Bayer, Astellas Pharma

What are the Application segmentation covered in the Gastric Mucosal Protective Drug Market report?

Ans: The Applications covered in the Gastric Mucosal Protective Drug Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Gastric Mucosal Protective Drug Market report?

Ans: The Types covered in the Gastric Mucosal Protective Drug Market report are Rebamipide, Sucralfate, Bismuth Potassium Citrate, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gastric Mucosal Protective Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Rebamipide

1.2.3 Sucralfate

1.2.4 Bismuth Potassium Citrate

1.2.5 Other

1.3 Market by Application

1.3.1 Global Gastric Mucosal Protective Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gastric Mucosal Protective Drug Market Perspective (2020-2031)

2.2 Global Gastric Mucosal Protective Drug Growth Trends by Region

2.2.1 Global Gastric Mucosal Protective Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Gastric Mucosal Protective Drug Historic Market Size by Region (2020-2025)

2.2.3 Gastric Mucosal Protective Drug Forecasted Market Size by Region (2026-2031)

2.3 Gastric Mucosal Protective Drug Market Dynamics

2.3.1 Gastric Mucosal Protective Drug Industry Trends

2.3.2 Gastric Mucosal Protective Drug Market Drivers

2.3.3 Gastric Mucosal Protective Drug Market Challenges

2.3.4 Gastric Mucosal Protective Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gastric Mucosal Protective Drug Players by Revenue

3.1.1 Global Top Gastric Mucosal Protective Drug Players by Revenue (2020-2025)

3.1.2 Global Gastric Mucosal Protective Drug Revenue Market Share by Players (2020-2025)

3.2 Global Top Gastric Mucosal Protective Drug Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Gastric Mucosal Protective Drug Revenue

3.4 Global Gastric Mucosal Protective Drug Market Concentration Ratio

3.4.1 Global Gastric Mucosal Protective Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gastric Mucosal Protective Drug Revenue in 2024

3.5 Global Key Players of Gastric Mucosal Protective Drug Head office and Area Served

3.6 Global Key Players of Gastric Mucosal Protective Drug, Product and Application

3.7 Global Key Players of Gastric Mucosal Protective Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Gastric Mucosal Protective Drug Breakdown Data by Type

4.1 Global Gastric Mucosal Protective Drug Historic Market Size by Type (2020-2025)

4.2 Global Gastric Mucosal Protective Drug Forecasted Market Size by Type (2026-2031)

5 Gastric Mucosal Protective Drug Breakdown Data by Application

5.1 Global Gastric Mucosal Protective Drug Historic Market Size by Application (2020-2025)

5.2 Global Gastric Mucosal Protective Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Gastric Mucosal Protective Drug Market Size (2020-2031)

6.2 North America Gastric Mucosal Protective Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Gastric Mucosal Protective Drug Market Size by Country (2020-2025)

6.4 North America Gastric Mucosal Protective Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gastric Mucosal Protective Drug Market Size (2020-2031)

7.2 Europe Gastric Mucosal Protective Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Gastric Mucosal Protective Drug Market Size by Country (2020-2025)

7.4 Europe Gastric Mucosal Protective Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gastric Mucosal Protective Drug Market Size (2020-2031)

8.2 Asia-Pacific Gastric Mucosal Protective Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Gastric Mucosal Protective Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Gastric Mucosal Protective Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gastric Mucosal Protective Drug Market Size (2020-2031)

9.2 Latin America Gastric Mucosal Protective Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Gastric Mucosal Protective Drug Market Size by Country (2020-2025)

9.4 Latin America Gastric Mucosal Protective Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gastric Mucosal Protective Drug Market Size (2020-2031)

10.2 Middle East & Africa Gastric Mucosal Protective Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Gastric Mucosal Protective Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Gastric Mucosal Protective Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Otsuka Pharmaceutical

11.1.1 Otsuka Pharmaceutical Company Details

11.1.2 Otsuka Pharmaceutical Business Overview

11.1.3 Otsuka Pharmaceutical Gastric Mucosal Protective Drug Introduction

11.1.4 Otsuka Pharmaceutical Revenue in Gastric Mucosal Protective Drug Business (2020-2025)

11.1.5 Otsuka Pharmaceutical Recent Development

11.2 Eisai Co.

11.2.1 Eisai Co. Company Details

11.2.2 Eisai Co. Business Overview

11.2.3 Eisai Co. Gastric Mucosal Protective Drug Introduction

11.2.4 Eisai Co. Revenue in Gastric Mucosal Protective Drug Business (2020-2025)

11.2.5 Eisai Co. Recent Development

11.3 Zhejaing Yuanlijian

11.3.1 Zhejaing Yuanlijian Company Details

11.3.2 Zhejaing Yuanlijian Business Overview

11.3.3 Zhejaing Yuanlijian Gastric Mucosal Protective Drug Introduction

11.3.4 Zhejaing Yuanlijian Revenue in Gastric Mucosal Protective Drug Business (2020-2025)

11.3.5 Zhejaing Yuanlijian Recent Development

11.4 Amneal Pharmaceuticals

11.4.1 Amneal Pharmaceuticals Company Details

11.4.2 Amneal Pharmaceuticals Business Overview

11.4.3 Amneal Pharmaceuticals Gastric Mucosal Protective Drug Introduction

11.4.4 Amneal Pharmaceuticals Revenue in Gastric Mucosal Protective Drug Business (2020-2025)

11.4.5 Amneal Pharmaceuticals Recent Development

11.5 Teva

11.5.1 Teva Company Details

11.5.2 Teva Business Overview

11.5.3 Teva Gastric Mucosal Protective Drug Introduction

11.5.4 Teva Revenue in Gastric Mucosal Protective Drug Business (2020-2025)

11.5.5 Teva Recent Development

11.6 Endo International

11.6.1 Endo International Company Details

11.6.2 Endo International Business Overview

11.6.3 Endo International Gastric Mucosal Protective Drug Introduction

11.6.4 Endo International Revenue in Gastric Mucosal Protective Drug Business (2020-2025)

11.6.5 Endo International Recent Development

11.7 Guangdong Huanan Pharma

11.7.1 Guangdong Huanan Pharma Company Details

11.7.2 Guangdong Huanan Pharma Business Overview

11.7.3 Guangdong Huanan Pharma Gastric Mucosal Protective Drug Introduction

11.7.4 Guangdong Huanan Pharma Revenue in Gastric Mucosal Protective Drug Business (2020-2025)

11.7.5 Guangdong Huanan Pharma Recent Development

11.8 Viatris

11.8.1 Viatris Company Details

11.8.2 Viatris Business Overview

11.8.3 Viatris Gastric Mucosal Protective Drug Introduction

11.8.4 Viatris Revenue in Gastric Mucosal Protective Drug Business (2020-2025)

11.8.5 Viatris Recent Development

11.9 Nostrum Pharmaceuticals

11.9.1 Nostrum Pharmaceuticals Company Details

11.9.2 Nostrum Pharmaceuticals Business Overview

11.9.3 Nostrum Pharmaceuticals Gastric Mucosal Protective Drug Introduction

11.9.4 Nostrum Pharmaceuticals Revenue in Gastric Mucosal Protective Drug Business (2020-2025)

11.9.5 Nostrum Pharmaceuticals Recent Development

11.10 LIVZON

11.10.1 LIVZON Company Details

11.10.2 LIVZON Business Overview

11.10.3 LIVZON Gastric Mucosal Protective Drug Introduction

11.10.4 LIVZON Revenue in Gastric Mucosal Protective Drug Business (2020-2025)

11.10.5 LIVZON Recent Development

11.11 AbbVie

11.11.1 AbbVie Company Details

11.11.2 AbbVie Business Overview

11.11.3 AbbVie Gastric Mucosal Protective Drug Introduction

11.11.4 AbbVie Revenue in Gastric Mucosal Protective Drug Business (2020-2025)

11.11.5 AbbVie Recent Development

11.12 Bayer

11.12.1 Bayer Company Details

11.12.2 Bayer Business Overview

11.12.3 Bayer Gastric Mucosal Protective Drug Introduction

11.12.4 Bayer Revenue in Gastric Mucosal Protective Drug Business (2020-2025)

11.12.5 Bayer Recent Development

11.13 Astellas Pharma

11.13.1 Astellas Pharma Company Details

11.13.2 Astellas Pharma Business Overview

11.13.3 Astellas Pharma Gastric Mucosal Protective Drug Introduction

11.13.4 Astellas Pharma Revenue in Gastric Mucosal Protective Drug Business (2020-2025)

11.13.5 Astellas Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Otsuka Pharmaceutical

Eisai Co Ltd

Amneal Pharmaceuticals

Guangdong Huanan Pharma

Nostrum Pharmaceuticals

List of Tables

Table 1. Global Gastric Mucosal Protective Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Rebamipide

Table 3. Key Players of Sucralfate

Table 4. Key Players of Bismuth Potassium Citrate

Table 5. Key Players of Other

Table 6. Global Gastric Mucosal Protective Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Gastric Mucosal Protective Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Gastric Mucosal Protective Drug Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Gastric Mucosal Protective Drug Market Share by Region (2020-2025)

Table 10. Global Gastric Mucosal Protective Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Gastric Mucosal Protective Drug Market Share by Region (2026-2031)

Table 12. Gastric Mucosal Protective Drug Market Trends

Table 13. Gastric Mucosal Protective Drug Market Drivers

Table 14. Gastric Mucosal Protective Drug Market Challenges

Table 15. Gastric Mucosal Protective Drug Market Restraints

Table 16. Global Gastric Mucosal Protective Drug Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Gastric Mucosal Protective Drug Market Share by Players (2020-2025)

Table 18. Global Top Gastric Mucosal Protective Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastric Mucosal Protective Drug as of 2024)

Table 19. Ranking of Global Top Gastric Mucosal Protective Drug Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Gastric Mucosal Protective Drug Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Gastric Mucosal Protective Drug, Headquarters and Area Served

Table 22. Global Key Players of Gastric Mucosal Protective Drug, Product and Application

Table 23. Global Key Players of Gastric Mucosal Protective Drug, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Gastric Mucosal Protective Drug Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Gastric Mucosal Protective Drug Revenue Market Share by Type (2020-2025)

Table 27. Global Gastric Mucosal Protective Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Gastric Mucosal Protective Drug Revenue Market Share by Type (2026-2031)

Table 29. Global Gastric Mucosal Protective Drug Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Gastric Mucosal Protective Drug Revenue Market Share by Application (2020-2025)

Table 31. Global Gastric Mucosal Protective Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Gastric Mucosal Protective Drug Revenue Market Share by Application (2026-2031)

Table 33. North America Gastric Mucosal Protective Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Gastric Mucosal Protective Drug Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Gastric Mucosal Protective Drug Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Gastric Mucosal Protective Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Gastric Mucosal Protective Drug Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Gastric Mucosal Protective Drug Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Gastric Mucosal Protective Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Gastric Mucosal Protective Drug Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Gastric Mucosal Protective Drug Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Gastric Mucosal Protective Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Gastric Mucosal Protective Drug Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Gastric Mucosal Protective Drug Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Gastric Mucosal Protective Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Gastric Mucosal Protective Drug Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Gastric Mucosal Protective Drug Market Size by Country (2026-2031) & (US$ Million)

Table 48. Otsuka Pharmaceutical Company Details

Table 49. Otsuka Pharmaceutical Business Overview

Table 50. Otsuka Pharmaceutical Gastric Mucosal Protective Drug Product

Table 51. Otsuka Pharmaceutical Revenue in Gastric Mucosal Protective Drug Business (2020-2025) & (US$ Million)

Table 52. Otsuka Pharmaceutical Recent Development

Table 53. Eisai Co. Company Details

Table 54. Eisai Co. Business Overview

Table 55. Eisai Co. Gastric Mucosal Protective Drug Product

Table 56. Eisai Co. Revenue in Gastric Mucosal Protective Drug Business (2020-2025) & (US$ Million)

Table 57. Eisai Co. Recent Development

Table 58. Zhejaing Yuanlijian Company Details

Table 59. Zhejaing Yuanlijian Business Overview

Table 60. Zhejaing Yuanlijian Gastric Mucosal Protective Drug Product

Table 61. Zhejaing Yuanlijian Revenue in Gastric Mucosal Protective Drug Business (2020-2025) & (US$ Million)

Table 62. Zhejaing Yuanlijian Recent Development

Table 63. Amneal Pharmaceuticals Company Details

Table 64. Amneal Pharmaceuticals Business Overview

Table 65. Amneal Pharmaceuticals Gastric Mucosal Protective Drug Product

Table 66. Amneal Pharmaceuticals Revenue in Gastric Mucosal Protective Drug Business (2020-2025) & (US$ Million)

Table 67. Amneal Pharmaceuticals Recent Development

Table 68. Teva Company Details

Table 69. Teva Business Overview

Table 70. Teva Gastric Mucosal Protective Drug Product

Table 71. Teva Revenue in Gastric Mucosal Protective Drug Business (2020-2025) & (US$ Million)

Table 72. Teva Recent Development

Table 73. Endo International Company Details

Table 74. Endo International Business Overview

Table 75. Endo International Gastric Mucosal Protective Drug Product

Table 76. Endo International Revenue in Gastric Mucosal Protective Drug Business (2020-2025) & (US$ Million)

Table 77. Endo International Recent Development

Table 78. Guangdong Huanan Pharma Company Details

Table 79. Guangdong Huanan Pharma Business Overview

Table 80. Guangdong Huanan Pharma Gastric Mucosal Protective Drug Product

Table 81. Guangdong Huanan Pharma Revenue in Gastric Mucosal Protective Drug Business (2020-2025) & (US$ Million)

Table 82. Guangdong Huanan Pharma Recent Development

Table 83. Viatris Company Details

Table 84. Viatris Business Overview

Table 85. Viatris Gastric Mucosal Protective Drug Product

Table 86. Viatris Revenue in Gastric Mucosal Protective Drug Business (2020-2025) & (US$ Million)

Table 87. Viatris Recent Development

Table 88. Nostrum Pharmaceuticals Company Details

Table 89. Nostrum Pharmaceuticals Business Overview

Table 90. Nostrum Pharmaceuticals Gastric Mucosal Protective Drug Product

Table 91. Nostrum Pharmaceuticals Revenue in Gastric Mucosal Protective Drug Business (2020-2025) & (US$ Million)

Table 92. Nostrum Pharmaceuticals Recent Development

Table 93. LIVZON Company Details

Table 94. LIVZON Business Overview

Table 95. LIVZON Gastric Mucosal Protective Drug Product

Table 96. LIVZON Revenue in Gastric Mucosal Protective Drug Business (2020-2025) & (US$ Million)

Table 97. LIVZON Recent Development

Table 98. AbbVie Company Details

Table 99. AbbVie Business Overview

Table 100. AbbVie Gastric Mucosal Protective Drug Product

Table 101. AbbVie Revenue in Gastric Mucosal Protective Drug Business (2020-2025) & (US$ Million)

Table 102. AbbVie Recent Development

Table 103. Bayer Company Details

Table 104. Bayer Business Overview

Table 105. Bayer Gastric Mucosal Protective Drug Product

Table 106. Bayer Revenue in Gastric Mucosal Protective Drug Business (2020-2025) & (US$ Million)

Table 107. Bayer Recent Development

Table 108. Astellas Pharma Company Details

Table 109. Astellas Pharma Business Overview

Table 110. Astellas Pharma Gastric Mucosal Protective Drug Product

Table 111. Astellas Pharma Revenue in Gastric Mucosal Protective Drug Business (2020-2025) & (US$ Million)

Table 112. Astellas Pharma Recent Development

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Gastric Mucosal Protective Drug Picture

Figure 2. Global Gastric Mucosal Protective Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Gastric Mucosal Protective Drug Market Share by Type: 2024 VS 2031

Figure 4. Rebamipide Features

Figure 5. Sucralfate Features

Figure 6. Bismuth Potassium Citrate Features

Figure 7. Other Features

Figure 8. Global Gastric Mucosal Protective Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Gastric Mucosal Protective Drug Market Share by Application: 2024 VS 2031

Figure 10. Hospital Case Studies

Figure 11. Retail Pharmacy Case Studies

Figure 12. Other Case Studies

Figure 13. Gastric Mucosal Protective Drug Report Years Considered

Figure 14. Global Gastric Mucosal Protective Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Gastric Mucosal Protective Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Gastric Mucosal Protective Drug Market Share by Region: 2024 VS 2031

Figure 17. Global Gastric Mucosal Protective Drug Market Share by Players in 2024

Figure 18. Global Gastric Mucosal Protective Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Gastric Mucosal Protective Drug Revenue in 2024

Figure 20. North America Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Gastric Mucosal Protective Drug Market Share by Country (2020-2031)

Figure 22. United States Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Gastric Mucosal Protective Drug Market Share by Country (2020-2031)

Figure 26. Germany Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Gastric Mucosal Protective Drug Market Share by Region (2020-2031)

Figure 34. China Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Gastric Mucosal Protective Drug Market Share by Country (2020-2031)

Figure 42. Mexico Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Gastric Mucosal Protective Drug Market Share by Country (2020-2031)

Figure 46. Turkey Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Gastric Mucosal Protective Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Otsuka Pharmaceutical Revenue Growth Rate in Gastric Mucosal Protective Drug Business (2020-2025)

Figure 50. Eisai Co. Revenue Growth Rate in Gastric Mucosal Protective Drug Business (2020-2025)

Figure 51. Zhejaing Yuanlijian Revenue Growth Rate in Gastric Mucosal Protective Drug Business (2020-2025)

Figure 52. Amneal Pharmaceuticals Revenue Growth Rate in Gastric Mucosal Protective Drug Business (2020-2025)

Figure 53. Teva Revenue Growth Rate in Gastric Mucosal Protective Drug Business (2020-2025)

Figure 54. Endo International Revenue Growth Rate in Gastric Mucosal Protective Drug Business (2020-2025)

Figure 55. Guangdong Huanan Pharma Revenue Growth Rate in Gastric Mucosal Protective Drug Business (2020-2025)

Figure 56. Viatris Revenue Growth Rate in Gastric Mucosal Protective Drug Business (2020-2025)

Figure 57. Nostrum Pharmaceuticals Revenue Growth Rate in Gastric Mucosal Protective Drug Business (2020-2025)

Figure 58. LIVZON Revenue Growth Rate in Gastric Mucosal Protective Drug Business (2020-2025)

Figure 59. AbbVie Revenue Growth Rate in Gastric Mucosal Protective Drug Business (2020-2025)

Figure 60. Bayer Revenue Growth Rate in Gastric Mucosal Protective Drug Business (2020-2025)

Figure 61. Astellas Pharma Revenue Growth Rate in Gastric Mucosal Protective Drug Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions